Whitehouse PJ - Search Results

1

Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force.

Cohen CA, Whitehouse PJ, Post SG, Gauthier S, Eberhart A, LeDuc L. Cohen CA, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1999 Apr-Jun;13(2):66-70. doi: 10.1097/00002093-199904000-00002. Alzheimer Dis Assoc Disord. 1999. PMID: 10372948

2

Alzheimer's Disease International and International Working Group for Harmonization of Dementia Drug Guidelines for research involving human subjects with dementia.

Brodaty H, Dresser R, Eisner M, Erkunjuntti T, Gauthier S, Graham N, Jonker C, Sachs G, Whitehouse P. Brodaty H, et al. Alzheimer Dis Assoc Disord. 1999 Apr-Jun;13(2):71-9. doi: 10.1097/00002093-199904000-00003. Alzheimer Dis Assoc Disord. 1999. PMID: 10372949 No abstract available.

3

Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer disease research).

High DM, Post SG, Whitehouse PJ. High DM, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1994;8(Suppl. 4):1-4. Alzheimer Dis Assoc Disord. 1994. PMID: 11657669 No abstract available.

4

Discourse ethics: research, dementia, and communication.

Post SG, Ripich DN, Whitehouse PJ. Post SG, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1994;8(Suppl. 4):58-65. Alzheimer Dis Assoc Disord. 1994. PMID: 11657675

5

Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.

High DM, Whitehouse PJ, Post SG, Berg L. High DM, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1994;8(Suppl. 4):66-74. Alzheimer Dis Assoc Disord. 1994. PMID: 11657676 No abstract available.

6

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.

Roberts JS, LaRusse SA, Katzen H, Whitehouse PJ, Barber M, Post SG, Relkin N, Quaid K, Pietrzak RH, Cupples LA, Farrer LA, Brown T, Green RC. Roberts JS, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):86-93. doi: 10.1097/00002093-200304000-00006. Alzheimer Dis Assoc Disord. 2003. PMID: 12794385 Clinical Trial.

7

Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Post SG, Beerman B, Brodaty H, Gaines AW, Gauthier SG, Geldmacher DS, Hill S, Homma A, Rossor MN, Whitehouse PJ, Winblad B. Post SG, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8. Alzheimer Dis Assoc Disord. 1997. PMID: 9305511 No abstract available.

8

Alzheimer disease ethics: a continuing area of public interest.

Post SG, Whitehouse PJ, Nelson JL, Sachs GA. Post SG, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1999 Apr-Jun;13(2):63-5. Alzheimer Dis Assoc Disord. 1999. PMID: 10372947 No abstract available.

9

A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.

Post SG, Stuckey JC, Whitehouse PJ, Ollerton S, Durkin C, Robbins D, Fallcreek SJ. Post SG, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 2001 Apr-Jun;15(2):80-8. doi: 10.1097/00002093-200104000-00007. Alzheimer Dis Assoc Disord. 2001. PMID: 11391089

10

Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging.

High DM, Whitehouse PJ, Post SG, Berg L. High DM, et al. Among authors: whitehouse pj. Alzheimer Dis Assoc Disord. 1994;8 Suppl 4:66-74. Alzheimer Dis Assoc Disord. 1994. PMID: 7695858 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters